cisatracurium besilate 5mg/2.5ml solution for injection vials
hospira uk ltd - cisatracurium besilate - solution for injection - 2mg/1ml
cisatracurium besilate 20mg/10ml solution for injection ampoules
viatris uk healthcare ltd - cisatracurium besilate - solution for injection - 2mg/1ml
cisatracurium besilate 150mg/30ml solution for injection vials
viatris uk healthcare ltd - cisatracurium besilate - solution for injection - 5mg/1ml
cisatracurium besilate 150mg/30ml solution for injection vials
accord-uk ltd - cisatracurium besilate - solution for injection - 5mg/1ml
cisatracurium besilate 20mg/10ml solution for injection vials
accord-uk ltd - cisatracurium besilate - solution for injection - 2mg/1ml
bridion 100mg/ml solution for i/v injection
n.v. organon - sugammadex (sugammadex sodium) - solution for i/v injection - 100mg/ml
bridion 100mg/ml solution for i/v injection
n.v. organon - sugammadex (sugammadex sodium) - solution for i/v injection - 100mg/ml
nimbex cisatracurium (as besilate) 150mg/30ml injection vial
aspen pharmacare australia pty ltd - cisatracurium besilate, quantity: 6.7 mg/ml (equivalent: cisatracurium, qty 5 mg/ml) - injection, solution - excipient ingredients: benzenesulfonic acid; water for injections - nimbex injection is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.
nimbex cisatracurium (as besilate) 50mg/25ml injection ampoule
aspen pharmacare australia pty ltd - cisatracurium besilate, quantity: 2.68 mg/ml (equivalent: cisatracurium, qty 2 mg/ml) - injection, solution - excipient ingredients: benzenesulfonic acid; water for injections - nimbex injection is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.
nimbex cisatracurium (as besilate) 20mg/10ml injection ampoule
aspen pharmacare australia pty ltd - cisatracurium besilate, quantity: 2.68 mg/ml (equivalent: cisatracurium, qty 2 mg/ml) - injection, solution - excipient ingredients: benzenesulfonic acid; water for injections - nimbex injection is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.